Search This Blog

Friday, November 1, 2019

Rhythm Pharmaceuticals EPS beats by $0.03

Rhythm Pharmaceuticals (NASDAQ:RYTM): Q3 GAAP EPS of -$1.04 beats by $0.03.
Cash and equivalents of $71.68M
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)